A phase I/II study of adoptive immunotherapy using donor liver graft-derived NK cell-enriched immune cells to prevent severe infection after liver transplantation
Saved in:
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2025-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11737672/?tool=EBI |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832592630673833984 |
---|---|
author | Masahiro Ohira Yuki Imaoka Koki Sato Koki Imaoka Tomoaki Bekki Takuya Yano Ryosuke Nakano Hiroshi Sakai Shintaro Kuroda Hiroyuki Tahara Kentaro Ide Tsuyoshi Kobayashi Yuka Tanaka Junko Tanaka Hideki Ohdan |
author_facet | Masahiro Ohira Yuki Imaoka Koki Sato Koki Imaoka Tomoaki Bekki Takuya Yano Ryosuke Nakano Hiroshi Sakai Shintaro Kuroda Hiroyuki Tahara Kentaro Ide Tsuyoshi Kobayashi Yuka Tanaka Junko Tanaka Hideki Ohdan |
author_sort | Masahiro Ohira |
collection | DOAJ |
format | Article |
id | doaj-art-30334ab8b4164935968dd932a4413394 |
institution | Kabale University |
issn | 1932-6203 |
language | English |
publishDate | 2025-01-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLoS ONE |
spelling | doaj-art-30334ab8b4164935968dd932a44133942025-01-21T05:31:40ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01201A phase I/II study of adoptive immunotherapy using donor liver graft-derived NK cell-enriched immune cells to prevent severe infection after liver transplantationMasahiro OhiraYuki ImaokaKoki SatoKoki ImaokaTomoaki BekkiTakuya YanoRyosuke NakanoHiroshi SakaiShintaro KurodaHiroyuki TaharaKentaro IdeTsuyoshi KobayashiYuka TanakaJunko TanakaHideki Ohdanhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11737672/?tool=EBI |
spellingShingle | Masahiro Ohira Yuki Imaoka Koki Sato Koki Imaoka Tomoaki Bekki Takuya Yano Ryosuke Nakano Hiroshi Sakai Shintaro Kuroda Hiroyuki Tahara Kentaro Ide Tsuyoshi Kobayashi Yuka Tanaka Junko Tanaka Hideki Ohdan A phase I/II study of adoptive immunotherapy using donor liver graft-derived NK cell-enriched immune cells to prevent severe infection after liver transplantation PLoS ONE |
title | A phase I/II study of adoptive immunotherapy using donor liver graft-derived NK cell-enriched immune cells to prevent severe infection after liver transplantation |
title_full | A phase I/II study of adoptive immunotherapy using donor liver graft-derived NK cell-enriched immune cells to prevent severe infection after liver transplantation |
title_fullStr | A phase I/II study of adoptive immunotherapy using donor liver graft-derived NK cell-enriched immune cells to prevent severe infection after liver transplantation |
title_full_unstemmed | A phase I/II study of adoptive immunotherapy using donor liver graft-derived NK cell-enriched immune cells to prevent severe infection after liver transplantation |
title_short | A phase I/II study of adoptive immunotherapy using donor liver graft-derived NK cell-enriched immune cells to prevent severe infection after liver transplantation |
title_sort | phase i ii study of adoptive immunotherapy using donor liver graft derived nk cell enriched immune cells to prevent severe infection after liver transplantation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11737672/?tool=EBI |
work_keys_str_mv | AT masahiroohira aphaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation AT yukiimaoka aphaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation AT kokisato aphaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation AT kokiimaoka aphaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation AT tomoakibekki aphaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation AT takuyayano aphaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation AT ryosukenakano aphaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation AT hiroshisakai aphaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation AT shintarokuroda aphaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation AT hiroyukitahara aphaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation AT kentaroide aphaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation AT tsuyoshikobayashi aphaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation AT yukatanaka aphaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation AT junkotanaka aphaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation AT hidekiohdan aphaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation AT masahiroohira phaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation AT yukiimaoka phaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation AT kokisato phaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation AT kokiimaoka phaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation AT tomoakibekki phaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation AT takuyayano phaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation AT ryosukenakano phaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation AT hiroshisakai phaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation AT shintarokuroda phaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation AT hiroyukitahara phaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation AT kentaroide phaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation AT tsuyoshikobayashi phaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation AT yukatanaka phaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation AT junkotanaka phaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation AT hidekiohdan phaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation |